Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew M. Evens, DO, MS
Robert H. Lurie Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
227 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Marin Cancer Care Inc
Greenbrae, California, United States
- Salinas Valley Memorial
Salinas, California, United States
- Stanford University Hospitals and Clinics
Stanford, California, United States
- the Medical Center of Aurora
Aurora, Colorado, United States
- Boulder Community Hospital
Boulder, Colorado, United States
- Rocky Mountain Cancer Centers-Boulder
Boulder, Colorado, United States
- Penrose-Saint Francis Healthcare
Colorado Springs, Colorado, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Colorado Cancer Research Program Ccop
Denver, Colorado, United States
- Exempla Saint Joseph Hospital
Denver, Colorado, United States
- Porter Adventist Hospital
Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Midtown
Denver, Colorado, United States
- Rocky Mountain Cancer Centers-Rose
Denver, Colorado, United States
- Rose Medical Center
Denver, Colorado, United States
- Comprehensive Cancer Care and Research Institute of Colorado Llc
Englewood, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Poudre Valley Hospital
Fort Collins, Colorado, United States
- Mountain Blue Cancer Care Center
Golden, Colorado, United States
- North Colorado Medical Center
Greeley, Colorado, United States
- Rocky Mountain Cancer Centers-Greenwood Village
Greenwood Village, Colorado, United States
- Rocky Mountain Cancer Centers-Lakewood
Lakewood, Colorado, United States
- Saint Anthony Hospital
Lakewood, Colorado, United States
- Littleton Adventist Hospital
Littleton, Colorado, United States
- Rocky Mountain Cancer Centers-Sky Ridge
Lone Tree, Colorado, United States
- Sky Ridge Medical Center
Lone Tree, Colorado, United States
- Longmont United Hospital
Longmont, Colorado, United States
- Mckee Medical Center
Loveland, Colorado, United States
- Parker Adventist Hospital
Parker, Colorado, United States
- Rocky Mountain Cancer Centers-Parker
Parker, Colorado, United States
- Saint Mary Corwin Medical Center
Pueblo, Colorado, United States
- North Suburban Medical Center
Thornton, Colorado, United States
- Exempla Lutheran Medical Center
Wheat Ridge, Colorado, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- Georgia Regents University Medical Center
Augusta, Georgia, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Rush - Copley Medical Center
Aurora, Illinois, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2011
- Primary completion
- 2 Dec 2019
- Completion
- 2 Dec 2019
- Last update posted
- 29 Jun 2023
- Registered enrollment
- 289
- Registry id
- NCT01216683
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.